Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P61278 (
somatostatin
)
22,083
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Although the promiscuous nature of G(16) allows it to interact with numerous G protein-coupled receptors, several G(i)-linked receptors are incapable of activating phospholipase C via G(16). A series of chimeras between Galpha(16) and Galpha(z) were constructed and assayed for their ability to mediate receptor-induced stimulation of phospholipase C. Two Galpha(16/z) chimeras harboring 25 or 44 Galpha(z)-specific sequences at their C termini (named 16z25 and 16z44) were capable of responding to 14 different G(i)-coupled receptors tested, including those that were either unable to associate with Galpha(16) (melatonin
Mel1c
) or activate Galpha(16) weakly (micro-opioid and type 1
somatostatin
). Agonist-induced stimulation of phospholipase C was more efficiently mediated (higher maximal and lower EC(50) value) by 16z44 than by Galpha(16). Both 16z25 and 16z44 were also coupled to G(s)- and G(q)-linked receptors. Incorporation of Galpha(z) sequence at the N terminus of Galpha(16) did not further enhance the ability of the chimeras to interact with G(i)-coupled receptors. Expression of the various chimeras was verified by immunodetection and functional analysis of their constitutively activated mutants. These results show that the incorporation of alpha4/beta6 and alpha5 regions of Galpha(z) into a Galpha(16) backbone can improve the recognition of G(i)-coupled receptors. Galpha(16/z) chimeras with expanded capability to interact with G(i)-linked receptors may be used to link orphan receptors to the stimulation of phospholipase C.
...
PMID:Incorporation of Galpha(z)-specific sequence at the carboxyl terminus increases the promiscuity of galpha(16) toward G(i)-coupled receptors. 1061 74